Current and Emerging Research Needs in Studying the NYC HIV–Drug Use Epidemic

REFERENCES

• Amesty, S., Rivera, A., & Fuller, C. (2011). Overview of HIV among injection drug users in New York City: Critical next steps to eliminate racial/ethnic disparities. Substance Use & Misuse, 46(2-3), 285–294.
   PubMed Web of Science ®Google Scholar
• Brenner, B. G., Roger, M., Routy, J. P., Moisi, D., Ntemgwa, M., Matte, C., (2007). High rates of forward transmission events after acute/early HIV-1 infection. Journal of Infectious Diseases, 195(7), 951–959.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2009). HIV/AIDS Surveillance Report, 2007. Retrieved July 2, 2010, from http://www.cdc.gov/hiv/topics/surveillance/resources/reports/ 2007report/table14.htm
   Google Scholar
• Cunningham, C., Sohler, N., Cooperman, N., Berg, K., Litwin, A., & Arnsten, J. (2011). Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users. Substance Use & Misuse, 46(2-3), 218–232.
   PubMed Web of Science ®Google Scholar
• Deren, S., Shedlin, M., Kang, S.-Y., & Cortes, D. (2011). HIV risk and prevention among Hispanic immigrants in NY: The salience of diversity. Substance Use & Misuse, 46(2-3), 254–263.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D., Arasteh, K., & Friedman, S. (2011). HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years. Substance Use & Misuse, 46(2-3), 131–139.
   PubMed Web of Science ®Google Scholar
• El-Bassel, N., Gilbert, L., Witte, S., Wu, E., & Chang, M. (2011). Intimate partner violence and HIV among drug-involved women: Contexts linking these two epidemics—Challenges and implications for prevention and treatment. Substance Use & Misuse, 46(2-3), 295–306.
   PubMed Web of Science ®Google Scholar
• Freudenberg, N. (2011). HIV in the epicenter of the epicenter: HIV and drug use among criminal justice populations in New York City, 1980–2007. Substance Use & Misuse, 46(2-3), 159–170.
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Bolyard, M., Khan, M., Maslow, C., Sandoval, M., Mateu-Gelabert, P., (2008). Group sex events and HIV/STI risk in an urban network. Journal of Acquired Immune Deficiency Syndromes, 49(4), 440–446.
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Bolyard, M., Mateu-Gelabert, P., Goltzman, P., Pawlowicz, M. P., Singh, D. Z., (2007). Some data-driven reflections on priorities in AIDS network research. AIDS and Behavior, 11(5), 641–651.
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Kottiri, B. J., Neaigus, A., Curtis, R., Vermund, S. H., & Des Jarlais, D. C. (2000). Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. American Journal of Epidemiology, 152(10), 913–922.
   PubMed Web of Science ®Google Scholar
• Friedman, S., Pouget, E., Chattejee, S., Cleland, C., Tempalski, B., Brady, J., (in press). Do drug arrests deter injection drug use? American Journal of Public Health.
   Google Scholar
• Friedman, S., Sandoval, M., Mateu-Gelabert, M., Meylakhs, P., & Des Jarlais D. C. (2011). Symbiotic goals and the prevention of blood-borne viruses among injection drug users. Substance Use & Misuse, 46(2-3), 307–315.
   PubMed Web of Science ®Google Scholar
• Furst, T., Curtis, R., & Balletto, R. (2011). The transformation of drug markets and its impact on HIV outreach to injection drug users in New York City, 1987–2008. Substance Use & Misuse, 46(2-3), 150–158.
   PubMed Web of Science ®Google Scholar
• Gwadz, M. V., Cylar, K., Leonard, N. R., Riedel, M., Herzog, N., Arredondo, G. N., (2010). An exploratory behavioral intervention trial to improve rates of screening for AIDS clinical trials among racial/ethnic minority and female persons living with HIV/AIDS. AIDS and Behavior, 14(3), 639–648.
   PubMed Web of Science ®Google Scholar
• Gwadz, M., Leonard, N., Cleland, C., Colon, P., Banfield, A., Middleton, S., (2010, July). Peer-driven intervention increases rates of screening for AIDS Clinical Trials among persons living with HIV/AIDS from racial/ethnic minority backgrounds. Paper presented at the XVIII International AIDS Conference, Vienna, Austria.
   Google Scholar
• Hagan, H., Perlman, D., & Des Jarlais, D. (2011). Sexual risk and HIV infection among drug users in New York City: a piolt study. Substance Use & Misuse, 46(2-3), 201–207.
   PubMed Web of Science ®Google Scholar
• Hagan, H., Thiede, H., & Des Jarlais, D. C. (2005). HIV/hepatitis C virus co-infection in drug users: Risk behavior and prevention. AIDS, 19(Suppl. 3), S199–S207.
   PubMed Web of Science ®Google Scholar
• Halkitis, P., Pollock, J., Pappas, M., Dayton, A., Moeller, R., Siconolfi, D., (2011). Substance use in the MSM population of New York City during the era of HIV/AIDS. Substance Use & Misuse, 46(2-3), 264–273.
   PubMed Web of Science ®Google Scholar
• Heller, D., & Paone, D. (2011). Access to sterile syringes for injecting drug users in New York City: Politics and perception (1984–2010). Substance Use & Misuse, 46(2-3), 140–149.
   PubMed Web of Science ®Google Scholar
• Jenness, S., Hagan, H., Liu, K.-L., Wendel, T., & Murrill, C. (2011). Continuing HIV risk in New York City injection drug users: The association of syringe source and syringe sharing. Substance Use & Misuse, 46(2-3), 192–200.
   PubMed Web of Science ®Google Scholar
• Klein, R. (2011). Trends related to aging and co-occurring disorders in HIV infected drug users. Substance Use & Misuse, 46(2-3), 233–244.
   PubMed Web of Science ®Google Scholar
• Marks, G., Crepaz, N., Senterfitt, J. W., & Janssen, R. S. (2005). Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: Implications for HIV prevention programs. Journal of Acquired Immune Deficiency Syndromes, 39(4), 446–453.
   PubMed Web of Science ®Google Scholar
• Mateu-Gelabert, P., Sandoval, M., Meylakhs, P., Wendel, T., & Friedman, S. R. (2010). Strategies to avoid opiate withdrawal: Implications for HCV and HIV risks. Journal of Drug Policy, 21(3), 179–185.
   PubMed Web of Science ®Google Scholar
• Mehta, S. H., Kirk, G. D., Astemborski, J., Galai, N., & Celentano, D. D. (2010). Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996–2008. Clinical Infectious Diseases, 50(12), 1664–1671.
   PubMed Web of Science ®Google Scholar
• Neaigus, A., Miller, M., Gyarmathy, A., & Friedman, S. (2011). HIV heterosexual sexual risk from injecting drug users among HIV seronegative non-injecting heroin users. Substance Use & Misuse, 46(2-3), 208–217.
   PubMed Web of Science ®Google Scholar
• Ompad, D., Friedman, S., Hwahng, S., Nandi, V., Fuller, C., & Vlahov, D. (2011). HIV risk behaviors among young drug using women who have sex with women (WSWs) in New York City. Substance Use & Misuse, 46(2-3), 274–284.
   PubMed Web of Science ®Google Scholar
• Pfeiffer, M., Hanna, D., Begier, E., Sepkowitz, K., Zimmerman, R., & Sackoff, J. (2011). Excess mortality among injection drug users with AIDS, New York City 1999–2004. Substance Use & Misuse, 46(2-3), 245–253.
   PubMed Web of Science ®Google Scholar
• Strauss, S., & Mino, M. (2011). Addressing the HIV-related needs of substance misusers in New York State: The benefits and barriers implementing a “one stop shopping” model. Substance Use & Misuse, 46(2-3), 171–180.
   PubMed Web of Science ®Google Scholar
• Strauss, S. M., Tiburcio, N. J., Munoz-Plaza, C., Gwadz, M., Lunievicz, J., Osborne, A., (2009). HIV care providers’ implementation of routine alcohol reduction support for their patients. AIDS Patient Care and STDs, 23(3), 211–218.
   PubMed Web of Science ®Google Scholar
• Vlahov, D., Ompad, D., Fuller, C., & Nandi, V. (2011). Comparison of HIV risk by duration of injection drug use. Substance Use & Misuse, 46(2-3), 181–191.
   PubMed Web of Science ®Google Scholar